Clinical Trials for Relapsed and/or Refractory Mature T Cell Malignancy

A Phase I Trial Anti-CC Chemokine Receptor 4 Chimeric Antigen Receptor T Cells (CCR4 CAR T Cells) for CCR4 Expressing T-cell Malignancies Including Peripheral T-cell Non-Hodgkin Lymphoma (PTCL) and Cutaneous T-cell Non-Hodgkin Lymphoma (CTCL)

NCT ID: NCT07055477

This clinical trial is studying a new gene therapy for certain types of mature T-cell cancers, including different forms of T-cell lymphoma that have come back or did not respond to previous treatm...